127 related articles for article (PubMed ID: 11807814)
1. Basic fibroblast growth factor modulates the expression of glycophorin A and c-kit and inhibits erythroid differentiation in K562 cells.
Burger PE; Lukey PT; Coetzee S; Wilson EL
J Cell Physiol; 2002 Jan; 190(1):83-91. PubMed ID: 11807814
[TBL] [Abstract][Full Text] [Related]
2. Modification of expression of stem cell factor by various cytokines.
Sugimoto Y; Koji T; Miyoshi S
J Cell Physiol; 1999 Nov; 181(2):285-94. PubMed ID: 10497307
[TBL] [Abstract][Full Text] [Related]
3. Basic fibroblast growth factor antagonizes activin A-mediated growth inhibition and hemoglobin synthesis in K562 cells by activating ERK1/2 and deactivating p38 MAP kinase.
Huang HM; Chang TW; Liu JC
Biochem Biophys Res Commun; 2004 Aug; 320(4):1247-52. PubMed ID: 15249224
[TBL] [Abstract][Full Text] [Related]
4. Mitogenic and anti-proliferative signals for neural crest cells and the neurogenic action of TGF-beta1.
Zhang JM; Hoffmann R; Sieber-Blum M
Dev Dyn; 1997 Mar; 208(3):375-86. PubMed ID: 9056641
[TBL] [Abstract][Full Text] [Related]
5. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
6. Basic fibroblast growth factor antagonizes transforming growth factor beta-mediated erythroid differentiation in K562 cells.
Burger PE; Dowdle EB; Lukey PT; Wilson EL
Blood; 1994 Apr; 83(7):1808-12. PubMed ID: 8142649
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells.
Ahdjoudj S; Kaabeche K; Holy X; Fromigué O; Modrowski D; Zérath E; Marie PJ
Exp Cell Res; 2005 Feb; 303(1):138-47. PubMed ID: 15572034
[TBL] [Abstract][Full Text] [Related]
9. Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK.
Huang HM; Chiou HY; Chang JL
J Cell Biochem; 2006 Jul; 98(4):789-97. PubMed ID: 16440334
[TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor inhibits p38-mediated cell differentiation and growth inhibition by activin A but not by histone deacetylase inhibitors in CML cells.
Chen CH; Lin JY; Liu FH; Chang JL; Huang HM
Ann Hematol; 2008 Mar; 87(3):175-82. PubMed ID: 17929017
[TBL] [Abstract][Full Text] [Related]
11. Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1).
Kenigsberg RL; Hong Y; Yao H; Lemieux N; Michaud J; Tautu C; Théorêt Y
Am J Pathol; 1997 Sep; 151(3):867-81. PubMed ID: 9284836
[TBL] [Abstract][Full Text] [Related]
12. bFGF signaling and v-Myb cooperate in sustained growth of primitive erythroid progenitors.
Bartůnek P; Pajer P; Karafiát V; Blendinger G; Dvorák M; Zenke M
Oncogene; 2002 Jan; 21(3):400-10. PubMed ID: 11821952
[TBL] [Abstract][Full Text] [Related]
13. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
[TBL] [Abstract][Full Text] [Related]
14. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
[TBL] [Abstract][Full Text] [Related]
15. Neurokinin-A inhibits cell cycle activators in K562 cells and activates Smad 4 through a non-canonical pathway: a novel method in neural-hematopoietic axis.
Ricardo M; Trzaska KA; Rameshwar P
J Neuroimmunol; 2008 Nov; 204(1-2):85-91. PubMed ID: 18760489
[TBL] [Abstract][Full Text] [Related]
16. [Basic fibroblast growth factor inhibits promoter activities of human alpha 1(I) procollagen gene induced by transforming growth factor-beta 1].
Wan WD; Yang SL; Gao CF
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Nov; 16(6):401-3. PubMed ID: 12508433
[TBL] [Abstract][Full Text] [Related]
17. [Effect of three growth factors on proliferation and cell phenotype of human fetal meniscal cells].
Ye C; Deng Z; Li B
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Oct; 21(10):1137-41. PubMed ID: 17990786
[TBL] [Abstract][Full Text] [Related]
18. Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.
Kawano T; Horiguchi-Yamada J; Saito S; Iwase S; Furukawa Y; Kano Y; Yamada H
Leuk Res; 2004 Jun; 28(6):623-9. PubMed ID: 15120940
[TBL] [Abstract][Full Text] [Related]
19. PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis.
Spinello I; Quaranta MT; Pasquini L; Pelosi E; Petrucci E; Pagliuca A; Castelli G; Mariani G; Diverio D; Foà R; Testa U; Labbaye C
Oncogene; 2009 Jun; 28(23):2276-88. PubMed ID: 19421145
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-2 maintains the differentiation potential of nucleus pulposus cells in vitro: implications for cell-based transplantation therapy.
Tsai TT; Guttapalli A; Oguz E; Chen LH; Vaccaro AR; Albert TJ; Shapiro IM; Risbud MV
Spine (Phila Pa 1976); 2007 Mar; 32(5):495-502. PubMed ID: 17334282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
